BNP PARIBAS FINANCIAL MARKETS - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,292,274
-0.7%
102,288
+80.3%
0.00%0.0%
Q2 2023$2,307,412
-39.6%
56,735
-28.1%
0.00%
-40.0%
Q1 2023$3,819,833
+49.5%
78,857
+17.8%
0.01%
+25.0%
Q4 2022$2,555,901
-99.9%
66,961
-4.2%
0.00%
-33.3%
Q3 2022$3,510,084,000
+161.0%
69,922
+108.3%
0.01%
+200.0%
Q2 2022$1,344,734,000
+27.8%
33,568
+19.0%
0.00%
+100.0%
Q1 2022$1,052,179,000
+81.4%
28,201
+93.6%
0.00%0.0%
Q4 2021$580,044,000
+24.5%
14,563
+16.3%
0.00%0.0%
Q3 2021$465,758,000
+325.3%
12,517
+383.1%
0.00%
Q2 2021$109,522,000
-70.7%
2,591
-67.2%
0.00%
-100.0%
Q1 2021$374,207,000
-33.8%
7,903
-14.7%
0.00%0.0%
Q4 2020$565,260,000
-17.3%
9,262
-36.6%
0.00%0.0%
Q3 2020$683,158,000
+101.3%
14,613
+118.5%
0.00%0.0%
Q2 2020$339,349,000
-90.0%
6,688
-91.2%
0.00%
-85.7%
Q1 2020$3,382,063,000
+717.0%
75,814
+779.6%
0.01%
+600.0%
Q4 2019$413,971,000
+18.0%
8,619
-16.9%
0.00%0.0%
Q3 2019$350,713,000
+10.1%
10,370
+46.5%
0.00%0.0%
Q2 2019$318,600,000
-29.8%
7,080
-41.3%
0.00%0.0%
Q1 2019$454,014,000
+1216.3%
12,062
+1100.2%
0.00%
Q4 2018$34,492,000
-71.4%
1,005
-60.8%
0.00%
Q3 2018$120,461,000
+84.3%
2,563
+32.2%
0.00%
Q2 2018$65,369,000
-72.1%
1,938
-77.6%
0.00%
Q1 2018$234,231,000
+66.0%
8,656
+2.3%
0.00%
Q4 2017$141,079,000
+67.6%
8,458
+111.2%
0.00%
Q3 2017$84,172,000
+7.9%
4,005
-5.9%
0.00%
Q2 2017$77,994,000
+1112.0%
4,255
+550.6%
0.00%
Q1 2017$6,435,000
-39.2%
654
-32.6%
0.00%
Q4 2016$10,583,000
-71.0%
970
-62.7%
0.00%
Q3 2016$36,468,000
+334.0%
2,603
+117.5%
0.00%
Q2 2016$8,403,000
-96.7%
1,197
-84.8%
0.00%
-100.0%
Q4 2015$254,858,000
+33.8%
7,866
+10.2%
0.00%
Q3 2015$190,531,000
+40.6%
7,136
+153.4%
0.00%
Q2 2015$135,534,000
+281.4%
2,816
+382.2%
0.00%
Q1 2015$35,536,000
-37.1%
584
-54.5%
0.00%
Q3 2014$56,465,000
+933.6%
1,283
+513.9%
0.00%
Q2 2014$5,463,000
+168.8%
209
+101.0%
0.00%
Q1 2014$2,032,000
-36.3%
104
-44.7%
0.00%
Q4 2013$3,190,0001880.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 161,083$9,831,0007.49%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 333,000$20,323,0005.55%
RTW INVESTMENTS, LP 4,221,836$257,659,0004.32%
GEORGE KAISER FAMILY FOUNDATION 90,011$10,766,0002.85%
SECTORAL ASSET MANAGEMENT INC 603,978$36,861,0002.60%
Redwood Investments, LLC 364,837$22,266,0001.90%
ARMISTICE CAPITAL, LLC 716,000$43,697,0001.49%
CM Management, LLC 25,000$1,526,0001.42%
Third Security, LLC 237,015$14,465,0001.32%
Sofinnova Investments, Inc. 316,478$19,315,0001.15%
View complete list of PTC THERAPEUTICS INC shareholders